Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H14 |
| Molecular Weight | 134.2182 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)C1=CC=CC=C1
InChI
InChIKey=ZJMWRROPUADPEA-UHFFFAOYSA-N
InChI=1S/C10H14/c1-3-9(2)10-7-5-4-6-8-10/h4-9H,3H2,1-2H3
| Molecular Formula | C10H14 |
| Molecular Weight | 134.2182 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of cell-surface hydrophobicity on bacterial conversion of water-immiscible chemicals in two-liquid-phase culture systems. | 2009-08 |
|
| Design of efficient zeolite sensor materials for n-hexane. | 2007-02-15 |
|
| Relative ototoxicity of 21 aromatic solvents. | 2005-06 |
|
| 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. | 2004-11-15 |
|
| Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. | 2003-10 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:30:24 GMT 2025
by
admin
on
Mon Mar 31 20:30:24 GMT 2025
|
| Record UNII |
B70I0RSX3J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135-98-8
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
35097
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
8466
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
B70I0RSX3J
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
8680
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
sec-Butylbenzene
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
C063840
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
m2822
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID2022333
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
205-227-0
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY | |||
|
7212
Created by
admin on Mon Mar 31 20:30:24 GMT 2025 , Edited by admin on Mon Mar 31 20:30:24 GMT 2025
|
PRIMARY |